Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 137 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

23 trials in Phase 3/4

Results Transparency

0 of 21 completed trials have results

Key Signals

60 recruiting

Enrollment Performance

Analytics

N/A

49(46.7%)

Phase 2

22(21.0%)

Phase 4

13(12.4%)

Phase 3

10(9.5%)

Phase 1

9(8.6%)

Early Phase 1

2(1.9%)

105Total

N/A(49)

Phase 2(22)

Phase 4(13)

Phase 3(10)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (137)

Showing 20 of 137 trials

NCT07569783Not ApplicableNot Yet Recruiting

tDCS for Reducing the Incidence of OEI After Cesarean Section

Role: lead

NCT04518475Phase 4Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Role: collaborator

NCT07132112Early Phase 1Recruiting

GT719 Injection for Moderate to Severe Refractory Autoimmune Disease

Role: collaborator

NCT07506668Phase 1Not Yet Recruiting

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Role: lead

NCT06230965Not ApplicableCompleted

Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment

Role: lead

NCT06220162Phase 2Recruiting

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Role: collaborator

NCT05376111Phase 2Recruiting

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

Role: collaborator

NCT07455253Active Not Recruiting

Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery

Role: lead

NCT07342283Phase 2Recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07382453Phase 2Not Yet Recruiting

Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases

Role: lead

NCT07375667Not ApplicableRecruiting

Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients

Role: lead

NCT06283758Not ApplicableRecruiting

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

Role: collaborator

NCT05387512Completed

A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer

Role: lead

NCT05657639Phase 2Recruiting

CAV Regimen for R/R AML

Role: collaborator

NCT05657652Not ApplicableRecruiting

CAV Regimen for R/R Ph- B-ALL

Role: collaborator

NCT05901974Phase 2Recruiting

Venetoclax Combined With Azactidine in the Treatment of ALAL

Role: collaborator

NCT07282301Recruiting

Evaluation of the Clinical Outcomes of the Embolic Protection System in Preventing Distal Embolism During Femoropopliteal Debulking Procedures

Role: collaborator

NCT07205536Phase 2Recruiting

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Role: lead